RIG
43
2
MET
61
5
COF
44
2
GPC
38
3
APH
50
-2
RF
48
4
NOC
51
6
AAP
27
-3
KMI
67
2
HUM
47
10
FITB
38
2
IVZ
33
3
HES
65
3
HSY
32
-2
AMT
28
4
WDC
37
-3
SYF
64
2
HON
52
-3
ITW
37
4
FIS
53
3
RIG
43
2
MET
61
5
COF
44
2
GPC
38
3
APH
50
-2
RF
48
4
NOC
51
6
AAP
27
-3
KMI
67
2
HUM
47
10
FITB
38
2
IVZ
33
3
HES
65
3
HSY
32
-2
AMT
28
4
WDC
37
-3
SYF
64
2
HON
52
-3
ITW
37
4
FIS
53
3
Financhill
Back

Summit Therapeutics 10K Form

Sell
46

SMMT
Summit Therapeutics

Last Price:
$16.66
Seasonality Move:
7.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-07 10Q SMMT/Summit Therapeutics Quarterly
2023-08-09 10Q SMMT/Summit Therapeutics Quarterly
2023-05-11 10Q SMMT/Summit Therapeutics Quarterly
2022-11-09 10Q SMMT/Summit Therapeutics Quarterly
2022-08-11 10Q SMMT/Summit Therapeutics Quarterly
2022-05-11 10Q SMMT/Summit Therapeutics Quarterly

Receive SMMT News And Ratings

See the #1 stock for the next 7 days that we like better than SMMT

SMMT Financial Statistics

Sales & Book Value

Annual Sales: $705K
Cash Flow: $-30.4M
Price / Cash Flow: 0
Annual Sales: $0.59
Price / Book: 30.61

Profitability

EPS (TTM): -0.24000
Net Income (TTM): $-196.7M
Gross Margin: $760K
Return on Equity: 0%
Return on Assets: 0%

Summit Therapeutics Earnings Forecast

Key Summit Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 15 years for SMMT is 102.29%.
  • The Selling, General & Administrative Expenses for SMMT have been equal to 3,787.23% of Gross Profit Margin.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Summit Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SMMT
CUSIP: 86627R
Website: smmttx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SMMT Technical Analysis vs Fundamental Analysis

Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy or a Sell?